Xbrane Biopharma Swells In Oncology With Keytruda And Darzalex Projects

With Opdivo Biosimilar, Three Products ‘Could Be Launched In 2028-2029’

Pair of aces with poker chips
Xbrane has announced a pair of new projects • Source: Alamy

More from Biosimilars

More from Products